5-Amino-1MQ is a small molecule derivative studied as a nicotinamide N-methyltransferase (NNMT) inhibitor
clinical protocols typically use 250-500 mcg per injection near the site of injury Cycle length: 6-12 weeks, followed by a 4-8 week break before repeating Research status: Evidence is almost entirely from rodent and small animal models, where BPC-157 has consistently improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries
This bypasses any potential absorption issues and gets that B12 straight to work, ensuring that it reaches your cells more quickly and efficiently
If you are new to peptide therapy or want guidance tailored to your goals, scheduling a Peptide Consultation with Extension Health allows for personalized recommendations and ongoing support.
Methylmalonic Acid Levels among Older Adults Older adults appear to have higher average MMA levels without apparent consequence
Use cases in research: Healing full-thickness skin wounds